Healthcare Technology Report September 9, 2024

On August 20, 2024, Johnson & Johnson disclosed that it has completed a definitive agreement to acquire V-Wave, a privately-held company that specializes in the development of innovative treatment options for heart failure patients. The acquisition, valued at an upfront payment of $600 million with the potential for additional milestone payments up to $1.1 billion, will integrate V-Wave...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
STAT+: How Trump’s tariffs may raise health care costs, from medical devices to prescription drugs
Medical device cyber updates must consider patient safety
Open Source Healthcare – The Cure for Stagnant Medical Innovation
Stryker to sell US spinal implants business to investment firm
Samsung Medison Launches AI-Powered Ultrasound System, Z20

Share This Article